Skip To Content

Medicare Insights

Through an integrated medical, pharmacy, claims and legal approach, we deliver insights to help navigate the ever‑changing Medicare Secondary Payer landscape.

Recent blog posts

December 15, 2022 · Medicare Insights Team
The Centers for Medicare and Medicaid Services (CMS) held a webinar on December 6, 2022, regarding Section 111 Non-Group Health Plan best practices, compliance tips and common errors. Read more...
November 21, 2022 · Medicare Insights Team
On November 14, 2022, The Centers for Medicare and Medicaid Services (CMS) released Version 3.8 of the Workers’ Compensation Medicare Set Aside Arrangement (WCMSA) Reference Guide. Some of the changes/additions in this version pertain to the Re-Review process. Read more...
October 31, 2022 · Medicare Insights Team
Optum is closely monitoring the progress and potential impact of a “Final Rule” for Medicare Secondary Payer (MSP) and certain Civil Money Penalties and a “Proposed Rule” regarding MSP and Future Medicals. Both have been under review with the Office of Information and Regulatory Affairs (OIRA) since March 1, 2022. Read more...
October 20, 2022 · Clinical Team
When it comes to unused prescription medications, the Drug Enforcement Agency (DEA) encourages everyone to “Keep them safe. Clean them out. Take them back.” They enforce this motto by sponsoring National Prescription Drug Take Back Days. Read more...
July 14, 2022 · Clinical Team
Effective June 30, 2022, Zelnorm 6 mg tablet will no longer be produced and marketed in the United States, as announced by its manufacturer, Alfasigma USA, Inc. Read more...
July 06, 2022 · Clinical Team
The U.S. Food and Drug Administration (FDA) approved Quviviq (daridorexant) 25 mg and 50 mg tablets on January 10, 2022. Manufactured by Idorsia Pharmaceuticals US Inc., this sedative/hypnotic is indicated for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Read more...
June 24, 2022 · Medicare Insights Team
On June 6, 2022, the Supreme Court ruled 7-2 in Gallardo v. Marstiller that Florida Medicaid was permitted reimbursement from a settlement involving a permanently disabled woman. The woman, Ms. Gallardo, was involved in a catastrophic injury when she was hit by a truck while exiting a school bus. Florida Medicaid previously paid $862,688.77 in medical expenses and was expected to continue paying for future medical expenses related to this incident. Read more...
May 05, 2022 · Medicare Insights Team
The Centers for Medicare and Medicaid Services (CMS) held a webinar on April 13, 2022, to discuss their new initiative, Go Paperless.  Go Paperless provides Responsible Reporting Entities (RREs) the ability to receive Medicare correspondence digitally through the Medicare Secondary Payer Recovery Portal (MSPRP). Read more...
     Next >>
Page 1 of 4
Clinical Connection
Policy Matters